SCHEMBL22284036

SCHEMBL22284036

ClC1=CC=C[C](c2cccc(Cl)c2Cl)C1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.37
CNR2 P34972 6/20 0.36
CNR1 P21554 2/20 0.36
CYP2D6 P10635 1/20 0.35
MAOA P21397 1/20 0.35
MAPK1 P28482 1/20 0.35
ADRA1A P35348 1/20 0.35
SCN4A P35499 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
PDE3A Q14432 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
IDO1 P14902 1/20 0.33
SLC9A1 P19634 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440943 0.67 TSHR (0.52) NOTUMCNR2CYP2D6MAOAMAPK1
SCHEMBL8674401 0.62
SCHEMBL29385608 0.61 CYP2A6 (0.52) NOTUMCYP2D6MAOAMAPK1ADRA1A
SCHEMBL381601 0.61 CYP2A6 (0.52) NOTUMCYP2D6MAOAMAPK1ADRA1A
SCHEMBL4456270 0.61 TSHR (0.46) NOTUMCNR2CYP2D6MAOAMAPK1
SCHEMBL8002110 0.61 NOTUM (0.36) NOTUMCNR2CNR1CYP2D6MAOA
SCHEMBL29274243 0.61 PTPN11 (0.54) NOTUMMAOAMAPK1IDO1TSHR
SCHEMBL811508 0.60 AHR (0.50) NOTUMCNR2CNR1CYP2D6MAOA
SCHEMBL29624838 0.60 TSHR (0.44) NOTUMCNR2CYP2D6MAOAMAPK1
SCHEMBL2229304 0.60 TSHR (0.44) NOTUMCNR2CYP2D6MAOAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200246332-A1 CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS OTSUKA PHARMA CO LTD (JP) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200246332-A1 CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS DRD2, CHRNA6, GABRA6 NOTUM 1699/4885CNR2 115/4885CNR1 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.